Kymera Therapeutics, Inc. · NASDAQ:KYMR

Booth Bruce sold 76,650 Kymera Therapeutics, Inc. shares (Form 4/A)

Traded Jun 29, 2026 · Filed Jul 2, 2026

On Jun 29, 2026, Booth Bruce (Director) sold 76,650 Kymera Therapeutics, Inc. shares at an average US$108.05 for US$8.28M under a trading plan, leaving 462,856 shares. Filed Jul 2, 2026 (Form 4/A).

Sold: 76,650 shares
Price: US$108.05 average (US$105.78 to US$111.20)
Value: US$8.28M
Holding after: 462,856 shares (held indirectly)
Trading plan: Yes (Made under a plan set in advance)
Role: Director

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Jun 29, 2026	Common Stock	Sale	5,549	US$105.78	2,446,375	Indirect
Jun 29, 2026	Common Stock	Sale	14,798	US$106.63	2,431,577	Indirect
Jun 29, 2026	Common Stock	Sale	19,419	US$107.76	2,412,158	Indirect
Jun 29, 2026	Common Stock	Sale	10,848	US$108.28	2,401,310	Indirect
Jun 29, 2026	Common Stock	Sale	7,968	US$109.75	2,393,342	Indirect
Jun 29, 2026	Common Stock	Sale	7,723	US$110.67	2,385,619	Indirect
Jun 29, 2026	Common Stock	Sale	934	US$111.20	2,384,685	Indirect
Jun 29, 2026	Common Stock	Sale	770	US$105.78	471,497	Indirect
Jun 29, 2026	Common Stock	Sale	2,133	US$106.63	469,364	Indirect
Jun 29, 2026	Common Stock	Sale	2,698	US$107.76	466,666	Indirect
Jun 29, 2026	Common Stock	Sale	1,498	US$108.28	465,168	Indirect
Jun 29, 2026	Common Stock	Sale	1,104	US$109.75	464,064	Indirect
Jun 29, 2026	Common Stock	Sale	1,078	US$110.67	462,986	Indirect
Jun 29, 2026	Common Stock	Sale	130	US$111.20	462,856	Indirect

Source

View original at SEC

Related